BriaCell Therapeutics Corp. (BCTX) Share-based Compensation (2019 - 2026)
BriaCell Therapeutics (BCTX) posted Share-based Compensation of $432207.0 for Q2 2026, up 51.2% sequentially from $285856.0 in Q1 2026, and up 92.25% YoY from $224815.0 in Q2 2025.
BriaCell Therapeutics Corp. (BCTX) Share-based Compensation (2019 - 2026) Analysis & Trends
BriaCell Therapeutics has reported Share-based Compensation for 7 years, with the latest figure at $432207.0 in Q2 2026.
- Quarterly Share-based Compensation rose 92.25% year-over-year to $432207.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $942878.0 (down 37.34% YoY) and the FY2025 annual result came in at $1.1 million, down 37.54% from the prior year.
- Share-based Compensation advanced to $432207.0 in Q2 2026 per BCTX's latest filing, from $285856.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $5.6 million in Q2 2022 and troughed at $224815.0 in Q2 2025.
- A 5-year average of $874128.7 and a median of $500155.0 in 2024 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2022 and 2023: Share-based Compensation soared 2335.1% in 2022, then slumped 94.97% in 2023.
- Over 5 years, Share-based Compensation stood at $1.1 million in 2022, then slumped by 51.99% to $533816.0 in 2023, then plunged by 49.99% to $266971.0 in 2024, then jumped by 549.74% to $1.7 million in 2025, then sank by 75.08% to $432207.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $432207.0, $285856.0, and $1.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 432,207.00 |
| Apr 30, 2026 | 432,207.00 |
| Jan 31, 2026 | 285,856.00 |
| Jan 31, 2026 | 285,856.00 |
| Oct 31, 2025 | 1.73 Mn |
| Oct 31, 2025 | 1.73 Mn |
| Apr 30, 2025 | 224,815.00 |
| Apr 30, 2025 | 224,815.00 |
| Jan 31, 2025 | 635,093.00 |
| Jan 31, 2025 | 635,093.00 |
| Oct 31, 2024 | 266,971.00 |
| Oct 31, 2024 | 266,971.00 |
| Jul 31, 2024 | 377,892.00 |
| Jul 31, 2024 | 377,892.00 |
| Apr 30, 2024 | 392,215.00 |
| Apr 30, 2024 | 392,215.00 |
| Jan 31, 2024 | 500,155.00 |
| Jan 31, 2024 | 500,155.00 |
| Oct 31, 2023 | 533,816.00 |
| Oct 31, 2023 | 533,816.00 |